These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1673654)

  • 1. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
    Koop H; Arnold R
    Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
    Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
    J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis.
    Ligumsky M; Lysy J; Siguencia G; Friedlander Y
    J Clin Gastroenterol; 2001 Jul; 33(1):32-5. PubMed ID: 11418787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.
    Koop H; Hotz J; Pommer G; Klein M; Arnold R
    Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
    Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
    Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
    Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
    Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
    Koop H; Katschinski M; Arnold R
    Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.
    Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Meuwissen SG
    Scand J Gastroenterol; 1990 Nov; 25(11):1144-50. PubMed ID: 1980377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
    Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
    Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omeprazole on serum gastrin levels: influence of age and sex.
    Koop H; Naumann-Koch C; Arnold R
    Z Gastroenterol; 1990 Nov; 28(11):603-5. PubMed ID: 1981116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
    Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.